SEPARATION AND Release AgreementSeparation and Release Agreement • November 4th, 2021 • NeuroBo Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 4th, 2021 Company Industry JurisdictionTHIS SEPARATION AND RELEASE AGREEMENT (this “Agreement”) is made and entered into as of November 3, 2021 by and between NeuroBo Pharmaceuticals, Inc., a Delaware corporation, whose address is 200 Berkeley Street, Office 19th Floor, Boston, Massachusetts 02116 (the “Company”) and Richard Kang, Ph.D. whose address is as reflected in the personnel records of the Company (“Employee”). Capitalized terms used but not defined in this Agreement will have the meanings ascribed to them in that Employment Agreement between Employee and the Company dated February 11, 2020 (the “Employment Agreement”).
Employment AgreementEmployment Agreement • November 4th, 2021 • NeuroBo Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 4th, 2021 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (this “Agreement”) by and between NeuroBo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Gil Price (the “Executive”) is signed by the Company and the Executive and is entered into on and made effective as of November 3, 2021 (the “Effective Date”).